Omnicell (OMCL) Net Equity Issued and Repurchased (2019)
Omnicell (OMCL) posted quarterly Net Equity Issued and Repurchased of $17.6 million for Q2 2019, down 12.99% quarter-over-quarter from $20.2 million in Q1 2019.
Omnicell (OMCL) Net Equity Issued and Repurchased (2019) Analysis & Trends
Omnicell (OMCL) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $17.6 million the latest figure, recorded in Q2 2019.
- In Q2 2019, Net Equity Issued and Repurchased changed N/A year-over-year to $17.6 million; the TTM figure through Mar 2020 stood at $17.6 million (changed N/A YoY), while the FY2019 annual figure was $37.8 million, down 4.45% from the prior year.
- Net Equity Issued and Repurchased slipped to $17.6 million in Q2 2019 per OMCL's latest filing, from $20.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $20.2 million in Q1 2019 and bottomed at $17.6 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Omnicell | 1.70 Bn | 1.41 Bn | 152.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 17.59 Mn |
| Jun 30, 2019 | 17.59 Mn |
| Mar 31, 2019 | 20.22 Mn |
| Mar 31, 2019 | 20.22 Mn |